Safety and efficacy of belimumab plus standard therapy for up to 13 years in patients with systemic lupus erythematosus.
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients.
Low aspirin use and high prevalence of pre-eclampsia risk factors among pregnant women in a multinational SLE inception cohort.
Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus.
